IMDX — Insight Molecular Diagnostics Inc.

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

About Insight Molecular Diagnostics Inc.

Insight Molecular Diagnostics Inc. operates as a precision diagnostics company in the United States and internationally. The company develops and commercializes laboratory developed tests, kitted research use only tests, and kitted clinical tests. It is developing DetermaCNI, a blood-based monitoring tool that detects progression early after one cycle cancer treatment; and DetermaIO, a gene expression test that assesses the tumor microenvironment… Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$6.41
Market Cap$190M
Float10.1M
Shares Outstanding32.3M
Price/Sales (TTM)97.42
Operating Margin (TTM)-32284.38%
Revenue (TTM)$1.9M
Dividend RateNone

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 $1.2M -$29.9M -$639,000 -$30.5M
2021 $2.2M -$64.1M $1.4M -$48.5M
2022 $958,000 -$72.9M -$18,000 -$13.3M
2023 $1.5M -$27.8M $413,000 -$23.1M
2024 $1.9M -$60.7M $740,000 -$59.0M
2025 $4.1M -$50.2M $190,000 -$28.4M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Jun 2025 $518,000 -$9.7M
Sep 2025 $260,000 -$10.9M
Dec 2025 $1.1M -$23.0M
Mar 2026 $32,000 -$4.3M

Ownership & Float

Insider Ownership20.0%
Institutional Ownership61.4%
Short Float7.1%
% of All Funds Holding0.47%
Number of Funds Holding39

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$4.62Near-term / short-term trend
Weekly40-Week SMA$5.19Medium-term trend
Weekly80-Week SMA$3.98Cyclical trend (business cycle)
Weekly200-Week SMA$5.01Secular trend (multi-year)
Monthly10-Month SMA$5.17Near-term monthly trend
Monthly20-Month SMA$3.97Medium-term monthly trend
Monthly40-Month SMA$3.85Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$3.10 support 3.74x 0 months ago
$4.00 support 3.02x 0 months ago
$2.10 support 1.51x 14 months ago

Historical Earnings Reactions (39 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap -0.04% 0.00% 41.03% 16.30% -9.41%
1 Day -1.82% -2.00% 38.46% 25.88% -21.67%
1 Week 0.13% -0.88% 43.59% 51.59% -30.51%
2 Weeks 0.66% -1.71% 42.11% 57.89% -30.45%
1 Month -1.33% -5.65% 44.74% 56.55% -38.83%

Next earnings: August 1, 2026 (65 days away)

Seasonality & Day-of-Week Patterns

Monthly Seasonality

MonthAvg ReturnWin RateSamples
Jan27.4%45.5%11
Feb-6.8%18.2%11
Mar-0.8%72.7%11
Apr-0.3%54.5%11
May-0.5%40.0%10
Jun-9.2%30.0%10
Jul-11.7%20.0%10
Aug1.5%50.0%10
Sep6.7%50.0%10
Oct-3.4%30.0%10
Nov4.7%50.0%10
Dec-0.7%40.0%10

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday -0.36% 39.4% 487
Tuesday 0.44% 41.0% 539
Wednesday -0.24% 44.5% 535
Thursday 0.33% 42.7% 527
Friday 0.31% 44.9% 526

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 61.4%

Insider Transactions — Smart Summary

Total insider ownership: 20.0%

12-Month Insider Activity Summary

Total Filings3
Net Value+N/A
Net Shares Change1,274,784
% of Float12.6%
C-Suite Filings0
Clusters Detected0

Key Insiders

NameTitleNet ValueFilingsActivity
BROADWOOD PARTNERS, L.P. +$5.7M 3 3 buy

Significant Filings

DateInsiderTitleNet ValuePrice After
2026-04-27 BROADWOOD PARTNERS, L.P. +$2.0M Transaction at $3.56, now +79.8%
2026-04-20 BROADWOOD PARTNERS, L.P. +$652,868.628 Transaction at $3.57, now +79.5%
2026-02-12 BROADWOOD PARTNERS, L.P. +$3.0M Transaction at $5.75, now +11.5%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Insight Molecular Diagnostics Inc. (IMDX) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for IMDX on Trend Edge →